Navigation Links
Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.
Date:2/29/2008

Lauds Company for Healthcare Innovation, Creating Local Jobs

LAWRENCE, Mass., Feb. 29 /PRNewswire-FirstCall/ -- Fifth District Congresswoman Niki Tsongas visited local medical device manufacturer NxStage Medical, Inc., at the company's headquarters in Lawrence last week. NxStage Medical is a growing public company whose novel portable technology makes it possible for people with kidney failure to have hemodialysis treatment at home or where they travel, and on a more frequent basis.

Tsongas met with representatives of NxStage, was briefed on its technology, and toured the company's facilities in the renovated Heritage Place mill complex at 439 South Union Street.

"I was pleased to visit NxStage last week to learn more about the exciting products and technology being developed by this innovative employer," said Tsongas. "NxStage is a leader in the healthcare industry and its presence in Lawrence exemplifies the kind of ground-breaking enterprise that is flourishing here in the Fifth District while providing outstanding local jobs."

Tsongas also met and talked with 34-year-old Marblehead-resident and NxStage patient Vanessa Evans, who is a part-time Spanish teacher and mother of two children. Evans began in-center hemodialysis in 1996, but after having her first child, the time commitment and physical toll of her treatments became too burdensome. Evans began training on the NxStage System One so she could have dialysis on a more frequent basis at home, on her own schedule.

"I was moved by Vanessa's story, which illustrated the tremendous benefits that the products developed by NxStage provide for those suffering from chronic kidney disease," said Tsongas.

"We are grateful to Congresswoman Tsongas for taking the time to visit, learn about our technology, and hear our views on the importance of achieving more favorable Medicare reimbursement for daily home therapy, which is not only less costly to perform and more convenient for patients, but appears to produce better clinical outcomes," said Joseph Turk, Jr., senior vice president of commercial operations for NxStage Medical.

"NxStage also commends Tsongas for her commitment to sustaining a regional environment that is friendly to company growth and entrepreneurship," continued Turk. "Since NxStage planted its roots in Lawrence, we have brought products from development to FDA approval, enjoyed a successful public offering, significantly expanded our facilities and enriched our workforce with many skilled employees from the local community."

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Contact:

Jane Hauser

Schwartz Communications

781-684-0770

nxstage@schwartz-pr.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First Lady Laura Bush Visits AED/Netmark Malaria-Control Project in Ghana
2. CRH Medical Corporation announces substantial increase in patient visits
3. A Reminder to Parents: Early Dental Visits Essential to Childrens Health
4. Depression not discussed during rheumatoid arthritis doctor visits
5. Patient Safety Authority Visits Facilities for Information on Wrong-Site Surgery
6. Holiday Visits Nudge Many Towards Senior Housing Decision
7. Where vets served affects frequency of ER visits but not hospital stays
8. NFL Legend John Madden Visits Capitol Hill;
9. Dramatic Growth Projected in Visits by Elderly Patients to Emergency Departments Underscores Urgency of Medicare Physician Payment Fix
10. 3 Common Drugs Trigger Most ER Visits by Seniors
11. Out-of-hours doctors reluctant to do home visits, say patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Calif. (PRWEB) , ... March 28, 2017 , ... ... its leading physicians, Paul Yost, will begin serving as new board chair for ... this month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
(Date:3/28/2017)... ... March 28, 2017 , ... A minimally invasive ... “perfect smile.” The National Association of Dental Laboratories (NADL) is informing dentists about ... aware of when utilizing dental laboratories and technicians that create these veneers. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... Association’s Tri-State Camp Conference in Atlantic City March 13-16, was a busy spot ... team of professional staff discussed strategies for preventing outbreaks among camp communities during ...
(Date:3/28/2017)... ... March 28, 2017 , ... Thank you to all ... February 8-10. , This event was exclusive to providers and offered an opportunity ... meeting took place at the Manchester Grand Hyatt where attendees gathered for a lively ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... SILVER SPRING, Md. , March 28, 2017 ... today approved Dupixent (dupilumab) injection to treat adults ... for patients whose eczema is not controlled adequately ... therapies are not advisable. Dupixent can be used ... approval of Dupixent demonstrates our commitment to approving ...
(Date:3/28/2017)... , March 28, 2017  "US Cancer ... on the various indicators and trend analysis related ... drugs in mainstream pharmaceutical market in US. The ... for the growth on cancer generics drugs in ... in saving of billions of dollars for various ...
(Date:3/28/2017)... PHOENIX , March 28, 2017  Today, ... Pharmacy released a new white paper to ... use of latex in healthcare. Specifically, there is substantial confusion ... fact, the FDA has urged manufacturers to drop the term ... labels, because of the challenge to ensure a product is ...
Breaking Medicine Technology: